Results from the first clinical trial of myopic LASIK with a new advanced wavefront-guided system are excellent and indicate the procedure is an acceptable and efficacious alternative to conventional LASIK.
Cheryl Guttman Krader
Anti-platelet-derived growth factor subunit B/anti-vascular endothelial growth factor benefits wet age-related macular degeneration
Recently released topline results from a phase Iib clinical trial of treatment for neovascular age-related macular degeneration show significantly greater improvement in visual acuity among patients receiving combination therapy with Fovista, an investigational aptamer directed against PDGF-B, plus anti-VEGF therapy compared with anti-VEGF therapy alone.
Data from multiple epidemiologic studies provide evidence linking myopia with an increased risk of open-angle glaucoma.
Refractive outcomes with toric IOL implantation can be improved by taking into account the astigmatism of both the anterior and posterior surfaces of the cornea.
Planned anisometropia in patients with long-standing diplopia who are undergoing bilateral cataract surgery can be a triple-win situation, providing clear uncorrected vision at both distance and near while simultaneously eliminating or reducing awareness of pre-existing double vision.
Results of defocus curve testing in eyes with a refractive multifocal IOL implanted as part of a prospective, multicenter comparative trial are better for the +3-D near-add version of the lens compared with the +4-D near-add platform with regard to intermediate visual acuity.
You might be reluctant to fit more children in contact lenses into your optical dispensary because you think it's difficult and time-consuming. However, the extra chair time is minimal, and the final rewards for the patient, the family, and you can be great, especially when contact lenses are medically necessary.
Results of a preclinical study demonstrate the feasibility of implanting a next-generation injectable version of a telescope prosthesis for end-stage macular degeneration and suggest it has promising advantages for improving surgical ease and safety.
On April 20, Abbott Medical Optics announced that it had received FDA clearance for use of the 150-kHz iFS advanced femtosecond laser to create arcuate incisions during corneal surgery, including cataract surgery.
Leading refractive surgeons agree wavefront-guided ablation is a significant advance in laser vision correction, but have different opinions about its role in treating myopic eyes with low higher-order aberrations.